This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (380)  • Contact me when this article is cited  Related Content  • Related letters  • Related articles  • Similar articles in JAMA  Social Bookmarking   What's this?

Is a Gift Ever Just a Gift?

Ashley Wazana, MD

JAMA. 2000;283:373-380.

Context  Controversy exists over the fact that physicians have regular contact with the pharmaceutical industry and its sales representatives, who spend a large sum of money each year promoting to them by way of gifts, free meals, travel subsidies, sponsored teachings, and symposia.

Objective  To identify the extent of and attitudes toward the relationship between physicians and the pharmaceutical industry and its representatives and its impact on the knowledge, attitudes, and behavior of physicians.

Data Sources  A MEDLINE search was conducted for English-language articles published from 1994 to present, with review of reference lists from retrieved articles; in addition, an Internet database was searched and 5 key informants were interviewed.

Study Selection  A total of 538 studies that provided data on any of the study questions were targeted for retrieval, 29 of which were included in the analysis.

Data Extraction  Data were extracted by 1 author. Articles using an analytic design were considered to be of higher methodological quality.

Data Synthesis  Physician interactions with pharmaceutical representatives were generally endorsed, began in medical school, and continued at a rate of about 4 times per month. Meetings with pharmaceutical representatives were associated with requests by physicians for adding the drugs to the hospital formulary and changes in prescribing practice. Drug company–sponsored continuing medical education (CME) preferentially highlighted the sponsor's drug(s) compared with other CME programs. Attending sponsored CME events and accepting funding for travel or lodging for educational symposia were associated with increased prescription rates of the sponsor's medication. Attending presentations given by pharmaceutical representative speakers was also associated with nonrational prescribing.

Conclusion  The present extent of physician-industry interactions appears to affect prescribing and professional behavior and should be further addressed at the level of policy and education.

Author Affiliation: McGill University, Montreal, Quebec.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTERS

Gifts to Physicians From the Pharmaceutical Industry
Steven M. Howard, David A. Edwards, Jochen Vollmann, W. Paul McKinney, Eugene C. Rich, Ashley Wazana, and Robert M. Tenery, Jr
JAMA. 2000;283(20):2655-2658.
EXTRACT | FULL TEXT  

Pharmaceutical Branding of Resident Physicians
Stephen K. Sigworth, Mary D. Nettleman, and Gail M. Cohen
JAMA. 2001;286(9):1024-1025.
EXTRACT | FULL TEXT  

Free Software and Physician Profiling
Alexander C. Tsai and Robert Hogan
JAMA. 2002;287(1):45.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Interactions Between Physicians and the Health Care Technology Industry
Robert M. Tenery, Jr
JAMA. 2000;283(3):391-393.
EXTRACT | FULL TEXT  

January 19, 2000
JAMA. 2000;283(3):411-412.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Relationships Between Drug Company Representatives and Medical Students:Medical School Policies and Attitudes of Student Affairs Deans and Third-Year Medical Students
Sierles et al.
Acad. Psychiatry 2009;33:478-483.
ABSTRACT | FULL TEXT  

Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?
Hietanen
Ann Oncol 2009;20:1749-1751.
FULL TEXT  

Dangerous liaisons? Industry relations with health professionals.
Sade
J Law Med Ethics 2009;37:398-400.
 

Altruism and self interest in medical decision making.
Rubin
J Law Med Ethics 2009;37:401-409.
 

Drug reps off campus! Promoting professional purity by suppressing commercial speech.
Stell
J Law Med Ethics 2009;37:431-443.
 

Public Perceptions of Health Care Professionals' Participation in Pharmaceutical Marketing
Crigger et al.
Nurs Ethics 2009;16:647-658.
ABSTRACT  

Impact of pharmaceutical representative visits on GPs' drug preferences
Sondergaard et al.
Fam Pract 2009;26:204-209.
ABSTRACT | FULL TEXT  

"But Doctors do it...": Nurses' Views of Gifts and Information from the Pharmaceutical Industry
Jutel and Menkes
The Annals of Pharmacotherapy 2009;43:1057-1063.
ABSTRACT | FULL TEXT  

Time for the Medical Profession to Act: New Policies Needed Now on Interactions Between Pharmaceutical Companies and Physicians
Greenland
Arch Intern Med 2009;169:829-831.
FULL TEXT  

Professional Medical Associations and Their Relationships With Industry: A Proposal for Controlling Conflict of Interest
Rothman et al.
JAMA 2009;301:1367-1372.
ABSTRACT | FULL TEXT  

Editorial: From Amrita to Substance D: Psychopharmacology, Political Economy, and Technologies of the Self
Kirmayer and Raikhel
Transcultural Psychiatry 2009;46:5-15.
 

Let us protest loudly
Yates et al.
BMJ 2009;338:b397-b397.
FULL TEXT  

The Promotion and Marketing of OxyContin: Commercial Triumph, Public Health Tragedy
Van Zee
AJPH 2009;99:221-227.
ABSTRACT | FULL TEXT  

Perspectives on Continuing Education in the Health Professions: Improving Health Care Through Lifelong Learning
Leach and Fletcher
Chest 2008;134:1299-1303.
ABSTRACT | FULL TEXT  

Who's watching the watchdogs?
Schwartz et al.
BMJ 2008;337:a2535-a2535.
FULL TEXT  

Guided Mentorship in Evidence-Based Medicine for Psychiatry: A Pilot Cohort Study Supporting a Promising Method of Real-Time Clinical Instruction
Mascola
Acad. Psychiatry 2008;32:475-483.
ABSTRACT | FULL TEXT  

New Developments in Managing Physician-Industry Relationships
Rothman and Chimonas
JAMA 2008;300:1067-1069.
FULL TEXT  

Is the relationship between pharma and medical education on the rocks?
Moynihan
BMJ 2008;337:a925-a925.
FULL TEXT  

Rethinking continuing medical education
Pisacane
BMJ 2008;337:a973-a973.
FULL TEXT  

Free lunches are not the answer
Montgomery
BMJ 2008;336:1034-1034.
FULL TEXT  

Exposing Nursing Students To the Marketing Methods of Pharmaceutical Companies
Civaner et al.
Nurs Ethics 2008;15:396-410.
ABSTRACT  

Pharmaceutical Promotion to Physicians and First Amendment Rights
Kesselheim and Avorn
NEJM 2008;358:1727-1732.
FULL TEXT  

Impugning the Integrity of Medical Science: The Adverse Effects of Industry Influence
DeAngelis and Fontanarosa
JAMA 2008;299:1833-1835.
FULL TEXT  

The need for an Institute of Continuing Health Education
Hebert
CMAJ 2008;178:805-806.
FULL TEXT  

Le besoin d'un Institut de l'education continue en sante
Hebert
CMAJ 2008;178:809-810.
FULL TEXT  

Has the hunt for conflicts of interest gone too far? Yes
Stossel
BMJ 2008;336:476-476.
FULL TEXT  

Has the hunt for conflicts of interest gone too far? No
Lee
BMJ 2008;336:477-477.
FULL TEXT  

Doctors' education: the invisible influence of drug company sponsorship
Moynihan
BMJ 2008;336:416-417.
FULL TEXT  

Corporate influences on epidemiology
Pearce
Int J Epidemiol 2008;37:46-53.
ABSTRACT | FULL TEXT  

News media coverage of direct-to-consumer pharmaceutical advertising: implications for countervailing powers theory
Hartley and Coleman
Health (London) 2008;12:107-132.
ABSTRACT  

Child psychiatry and its relationship with the pharmaceutical industry: theoretical and practical issues
Timimi
Adv. Psychiatr. Treat. 2008;14:3-9.
ABSTRACT | FULL TEXT  

To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-Trainee and Industry-Physician Relationships?
Carroll et al.
Pediatrics 2007;120:e1528-e1535.
ABSTRACT | FULL TEXT  

Politely Refuse the Pen and Note Pad: Gifts From Industry to Physicians Harm Patients
Iserson et al.
Ann. Thorac. Surg. 2007;84:1077-1084.
FULL TEXT  

Professionalism in Pediatrics
Fallat et al.
Pediatrics 2007;120:e1123-e1133.
ABSTRACT | FULL TEXT  

Pharmacy residents' attitudes toward pharmaceutical industry promotion
Ashker and Burkiewicz
Am J Health Syst Pharm 2007;64:1724-1731.
ABSTRACT | FULL TEXT  

General practitioners and pharmaceutical sales representatives: quality improvement research
Spurling and Mansfield
Qual Saf Health Care 2007;16:266-270.
ABSTRACT | FULL TEXT  

Conflict of Interest in Clinical Practice
Tonelli
Chest 2007;132:664-670.
ABSTRACT | FULL TEXT  

Prescriber Profiling: Time to Call It Quits
Grande
ANN INTERN MED 2007;146:751-752.
FULL TEXT  

Managing Conflict of Interest in Clinical Practice
Camilleri and Cortese
Mayo Clin Proc. 2007;82:607-614.
FULL TEXT  

A National Survey of Physician-Industry Relationships
Campbell et al.
NEJM 2007;356:1742-1750.
ABSTRACT | FULL TEXT  

Pharmaceutical Company Payments to Physicians: Early Experiences With Disclosure Laws in Vermont and Minnesota
Ross et al.
JAMA 2007;297:1216-1223.
ABSTRACT | FULL TEXT  

Conflicts of Interest and the Physician-Patient Relationship in the Era of Direct-to-Patient Advertising
Jagsi
JCO 2007;25:902-905.
FULL TEXT  

Medical Education and the Pharmaceutical Industry: A Review of Ethical Guidelines and Their Implications for Psychiatric Training
Geppert
Acad. Psychiatry 2007;31:32-39.
ABSTRACT | FULL TEXT  

Measuring the Impact of Medical Research: Moving From Outputs to Outcomes
Weiss
Am. J. Psychiatry 2007;164:206-214.
ABSTRACT | FULL TEXT  

Interactions Between Physicians and Industry: A Guide for Clinicians
Jibson
Focus 2007;5:398-406.
ABSTRACT | FULL TEXT  

Ask the Expert: Ethics and Professionalism
Jibson
Focus 2007;5:415-416.
FULL TEXT  

Bibliography for Ethics, Professionalism, and End of Life Care
Focus 2007;5:417-419.
FULL TEXT  

Abstracts for Ethics, Professionalism, and End of Life Care
Focus 2007;5:420-422.
FULL TEXT  

"Our parents, ourselves".
Turiel
JAMA 2006;296:2092-2093.
FULL TEXT  

Interactions of doctors with the pharmaceutical industry.
Morgan et al.
J. Med. Ethics 2006;32:559-563.
ABSTRACT | FULL TEXT  

Industry gifts to healthcare providers: are the concerns serious?
Day
Am J Crit Care 2006;15:510-513.
FULL TEXT  

Optimizing Outcomes in Psychopharmacology Continuing Medical Education (CME): Measuring Learning and Attitudes That May Predict Knowledge Translation into Clinical Practice
Stahl et al.
Focus 2006;4:487.
ABSTRACT | FULL TEXT  

Effects of Using Free Sample Medications on the Prescribing Practices of Family Physicians
Symm et al.
J Am Board Fam Med 2006;19:443-449.
ABSTRACT | FULL TEXT  

Overprescribing of lipid lowering agents.
Smith et al.
Qual Saf Health Care 2006;15:251-257.
ABSTRACT | FULL TEXT  

How Conducting a Clinical Trial Affects Physicians' Guideline Adherence and Drug Preferences
Andersen et al.
JAMA 2006;295:2759-2764.
ABSTRACT | FULL TEXT  

Clinical Trial Investigators and Their Prescribing Patterns: Another Dimension to the Relationship Between Physician Investigators and the Pharmaceutical Industry
Psaty and Rennie
JAMA 2006;295:2787-2790.
FULL TEXT  

Relationships between paediatricians and infant formula milk companies.
Wright and Waterston
Arch. Dis. Child. 2006;91:383-385.
FULL TEXT  

Can Health Journalists Bridge the State-of-the-Science Gap in Mammography Guidelines?
Chew et al.
Science Communication 2006;27:331-351.
ABSTRACT  

Murky waters: the pharmaceutical industry and psychiatrists in developing countries
Khan
Psychiatr. Bull. 2006;30:85-88.
FULL TEXT  

Current Status of Medical Grand Rounds in Departments of Medicine at US Medical Schools
Mueller et al.
Mayo Clin Proc. 2006;81:313-321.
ABSTRACT | FULL TEXT  

Medical Education and the Pharmaceutical Industry: Managing an Uneasy Alliance
Jibson
Acad. Psychiatry 2006;30:36-39.
FULL TEXT  

The Role of the Pharmaceutical Industry in Medical Education in Psychiatry
Lazarus
Acad. Psychiatry 2006;30:40-44.
FULL TEXT  

Health Industry Practices That Create Conflicts of Interest: A Policy Proposal for Academic Medical Centers
Brennan et al.
JAMA 2006;295:429-433.
ABSTRACT | FULL TEXT  

Differences in prescribing between GPs. Impact of the cooperation with pharmacists and impact of visits from pharmaceutical industry representatives
Muijrers et al.
Fam Pract 2005;22:624-630.
ABSTRACT | FULL TEXT  

Ties That Bind: Multiple Relationships Between Clinical Researchers and the Pharmaceutical Industry
Henry et al.
Arch Intern Med 2005;165:2493-2496.
ABSTRACT | FULL TEXT  

Excluding the experts?
Choi
CMAJ 2005;173:849-849.
FULL TEXT  

Medical Students' Exposure to and Attitudes About Drug Company Interactions: A National Survey
Sierles et al.
JAMA 2005;294:1034-1042.
ABSTRACT | FULL TEXT  

Selling Sickness: How the World's Pharmaceutical Companies Are Turning Us All Into Patients; Selling Sickness
Yom
JAMA 2005;294:1114-1116.
FULL TEXT  

Conflict of Interest: Can We Minimize Its Influence in the Biomedical Literature?
Neale et al.
J Am Board Fam Med 2005;18:411-413.
FULL TEXT  

The Contract Research Organization and the Commercialization of Scientific Research
Mirowski and Van Horn
Social Studies of Science 2005;35:503-548.
ABSTRACT  

New Federal Guidelines For Physician-Pharmaceutical Industry Relations: The Politics Of Policy Formation
Chimonas and Rothman
Health Aff (Millwood) 2005;24:949-960.
ABSTRACT | FULL TEXT  

Psychiatric Training Program Engagement With the Pharmaceutical Industry: An Educational Issue, Not Strictly an Ethical One
Mohl
Acad. Psychiatry 2005;29:215-221.
ABSTRACT | FULL TEXT  

The Role of the Pharmaceutical Industry in Teaching Psychopharmacology: A Growing Problem
Brodkey
Acad. Psychiatry 2005;29:222-229.
ABSTRACT | FULL TEXT  

Attitudes and Behaviors of Psychiatry Residents Toward Pharmaceutical Representatives Before and After an Educational Intervention
Randall et al.
Acad. Psychiatry 2005;29:33-39.
ABSTRACT | FULL TEXT  

Psychiatry and the pharmaceutical industry: who pays the piper?: A perspective from the Critical Psychiatry Network
Moncrieff et al.
Psychiatr. Bull. 2005;29:84-85.
FULL TEXT  

The role of the pharmaceutical industry in neurologic education
Gelb
Neurology 2005;64:E7-E10.
FULL TEXT  

Does the C in CME stand for "Continuing" or "Commercial"?
Lexchin and Cassels
CMAJ 2005;172:160-162.
FULL TEXT  

The Company We Keep: Why Physicians Should Refuse to See Pharmaceutical Representatives
Brody
Ann Fam Med 2005;3:82-85.
ABSTRACT | FULL TEXT  

Doctors and Drug Companies
Blumenthal
NEJM 2004;351:1885-1890.
FULL TEXT  

Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry -- Self-Regulation in the Shadow of Federal Prosecution
Studdert et al.
NEJM 2004;351:1891-1900.
FULL TEXT  

Promotion and Prescribing of Hormone Therapy After Report of Harm by the Women's Health Initiative
Majumdar et al.
JAMA 2004;292:1983-1988.
ABSTRACT | FULL TEXT  

Continuing Medical Education in Diabetes: The Impending Crisis
Leichter
Clin. Diabetes 2004;22:174-177.
FULL TEXT  

Privacy of pharmacy prescription records
Zoutman et al.
CMAJ 2004;171:712-712.
FULL TEXT  

Cost-Related Medication Underuse: Do Patients With Chronic Illnesses Tell Their Doctors?
Piette et al.
Arch Intern Med 2004;164:1749-1755.
ABSTRACT | FULL TEXT  

CME and the pharmaceutical industry: two worlds, three views, four steps
Davis
CMAJ 2004;171:149-150.
FULL TEXT  

The future sponsorship of CME in Canada: Industry, government, physicians or a blend?
Marlow
CMAJ 2004;171:150-151.
FULL TEXT  

State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction
Patel et al.
J Am Coll Cardiol 2004;44:192-198.
ABSTRACT | FULL TEXT  

Ethical Concerns in Industry Support of Continuing Medical Education: The Con Side
Packer and Parke
Arch Ophthalmol 2004;122:773-776.
FULL TEXT  

Manufacturing Desire:: The Commodification of Female Sexual Dysfunction
Fishman
Social Studies of Science 2004;34:187-218.
ABSTRACT  

Attention to 'Details':: Etiquette and the Pharmaceutical Salesman in Postwar American
Greene
Social Studies of Science 2004;34:271-292.
ABSTRACT  

Reimbursement Incentives to Physicians
Capozzi and Delsignore
JBJS 2004;86:876-877.
FULL TEXT  

The confidentiality of patient and physician information in pharmacy prescription records
Zoutman et al.
CMAJ 2004;170:815-816.
FULL TEXT  

Impact of Clinical Trial Results on National Trends in {alpha}-Blocker Prescribing, 1996-2002
Stafford et al.
JAMA 2004;291:54-62.
ABSTRACT | FULL TEXT  

Are Gifts From Pharmaceutical Companies Ethically Problematic?: A Survey of Physicians
Brett et al.
Arch Intern Med 2003;163:2213-2218.
ABSTRACT | FULL TEXT  

Policies to Regulate Gifts to Physicians From Industry
Tsai
JAMA 2003;290:1776-1776.
FULL TEXT  

Cost and Quality of Industry-Sponsored Meals for Medical Residents
Grande and Volpp
JAMA 2003;290:1150-1151.
FULL TEXT  

A Social Science Perspective on Gifts to Physicians From Industry
Dana and Loewenstein
JAMA 2003;290:252-255.
FULL TEXT  

Developing and Implementing a Program of Grand Rounds for Internists That Is Free of Commercial Bias
McMahon et al.
ANN INTERN MED 2003;139:77-78.
FULL TEXT